Our team

Victor Tetz, MD, Ph.D
Victor Tetz, MD, Ph.D
Serves as a Scientific Advisor who is responsible for the strategic planning for TGV-Therapeutics.
George Tetz, MD, Ph.D
George Tetz, MD, Ph.D
Serves as CEO. He comes from a rich background, including industrial, academic, and nonprofit organizations.
Jeffrey A. Gelfand, MD, Ph.D
Jeffrey A. Gelfand, MD, Ph.D
Professor and Chairman of the Department of Medicine at Tufts and Physician-in-Chief at the New England Medical center.
Dr. Michelle Welborn
Dr. Michelle Welborn
Dr. Michelle Welborn, serves as a pharmaceutical consultant and provides regulatory consulting to manage the project in FDA.
Sushant Kumar, MD, Ph.D
Sushant Kumar, MD, Ph.D
Dr Sushant is responsible for the management of all operational aspects and investment.
Haran Schlamm, MD
Haran Schlamm, MD
Dr. Haran Schlamm, is a globally recognized infectious disease-trained physician.
Michael Cynamon, MD, Ph.D
Michael Cynamon, MD, Ph.D
Dr, Cynamon serves as a Member of Scientific Advisory Board.